Pfizer

Pfizer to acquire InnoPharma

Thursday, July 17, 2014 12:48 PM

Pfizer has entered an agreement to acquire InnoPharma, a privately held pharmaceutical development company, for an upfront cash payment of $225 million, with up to $135 million of contingent milestone payments.

More... »

WIRB Copernicus Group

Global Care Initiative looks to Boston for U.S. life science research partners

Monday, June 23, 2014 01:36 PM

Global Care Initiative(GCI), a consortium of five nonprofit French research institutes, intends to have a representative in Boston, Mass., as it expands in search of U.S. life science research partners.

More... »

CRF Health eCOA webinar series

Sorbent Therapeutics appoints two new board members

Thursday, June 19, 2014 02:27 PM

Sorbent Therapeutics, a biopharmaceutical company developing therapies for cardiovascular and renal diseases, has appointed Jay Shepard and William D. Waddill to the company's board of directors.

More... »

Pfizer, Cellectis enter global cancer immunotherapy collaboration

Wednesday, June 18, 2014 12:47 PM

Pfizer and Cellectis, a biopharmaceutical company focused on oncology, have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies directed at select targets.

More... »

Pfizer opens new R&D site in Cambridge, Mass.

Tuesday, June 17, 2014 11:08 AM

Pfizer has announced the opening of a new 280,000-square-foot R&D hub in Cambridge, Mass. The new Pfizer facilities in Kendall Square bring together 1,000 colleagues from three area locations and positions Pfizer in closer proximity to leading academic institutions, hospitals and patient organizations.

More... »

Amgen joins NCI to accelerate development of personalized cancer treatments

Tuesday, June 17, 2014 10:26 AM

Amgen will collaborate with the National Cancer Institute (NCI), part of the NIH, and other public and private sector partners, on the Lung Master Protocol (Lung-MAP), a new clinical trial program that will use biomarker-driven research and genomic profiling to match squamous cell lung cancer patients to investigational treatments based on their individual cancer profiles. Lung-MAP is the first trial of its kind to study a large number of rare lung cancer subsets under one trial protocol.

More... »

Latest AAHRPP accreditations include N.Y. State Department of Health

Thursday, June 12, 2014 01:40 PM

The Association for the Accreditation of Human Research Protection Programs has accredited three more organizations, including one of the nation's largest state health departments and India's national comprehensive cancer center. A nonprofit organization, AAHRPP provides accreditation for organizations that conduct or review human research and can demonstrate that their protections exceed the safeguards required by the U.S. government.

More... »

X-Chem, Pfizer enter multi-target collaboration

Thursday, June 12, 2014 01:35 PM

X-Chem, a privately held biotechnology company applying its discovery capabilities to the generation of novel small molecule therapeutics, has announced a multi-target collaboration with Pfizer. The collaboration is focused on the potential development of several programs for the treatment of inflammatory and orphan diseases.

More... »

Kite Pharma appoints William Y. Go, Jeff Aycock senior directors

Thursday, June 12, 2014 12:54 PM

Kite Pharma, a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT) products for the treatment of cancer, has expanded Kite's R&D leadership team with the appointments of William Y. Go, M.D., Ph.D., as senior director, Clinical Development, and Jeff Aycock as senior director, Clinical Operations.

More... »

BioRestorative Therapies, Pfizer ink research agreement

Friday, May 23, 2014 10:30 AM

BioRestorative Therapies, a life sciences company focused on adult stem cell-based therapies for various personal medical applications, has entered into a two-year collaborative research agreement with Pfizer to study human brown adipose tissue and cell lines.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 21

As job growth in drug development sector soars, more employees are seeking new opportunities

U.K. study: Prisoners should have the right to participatein clinical trials on moral grounds, for healthcare access

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs